[go: up one dir, main page]

SE9802206D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE9802206D0
SE9802206D0 SE9802206A SE9802206A SE9802206D0 SE 9802206 D0 SE9802206 D0 SE 9802206D0 SE 9802206 A SE9802206 A SE 9802206A SE 9802206 A SE9802206 A SE 9802206A SE 9802206 D0 SE9802206 D0 SE 9802206D0
Authority
SE
Sweden
Prior art keywords
novel compounds
compounds
formula
intermediates
pain
Prior art date
Application number
SE9802206A
Other languages
Swedish (sv)
Inventor
Daniel Delorme
Vlad Gregor
Edward Roberts
Eric Sun
Original Assignee
Astra Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Inc filed Critical Astra Pharma Inc
Priority to SE9802206A priority Critical patent/SE9802206D0/en
Publication of SE9802206D0 publication Critical patent/SE9802206D0/en
Priority to AU48145/99A priority patent/AU4814599A/en
Priority to EP99931709A priority patent/EP1087940A1/en
Priority to PCT/SE1999/001074 priority patent/WO1999067203A1/en
Priority to CA002335536A priority patent/CA2335536A1/en
Priority to ARP990102988A priority patent/AR030143A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/16—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings
    • C07C211/18—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings containing at least two amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/37—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/86—Ring systems containing bridged rings containing four rings
    • C07C2603/88—Ethanoanthracenes; Hydrogenated ethanoanthracenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compounds of general formula (I) wherein A is (a) or (b); Z is (CH2)m or a carbonyl group are disclosed and claimed in the present application, as well as their pharmaceutically acceptable salts, pharmaceutical compositions comprising the novel compounds and their use in therapy, in particular in the management of pain. Also intermediates to the compounds of formula (I) are claimed.
SE9802206A 1998-06-22 1998-06-22 Novel compounds SE9802206D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE9802206A SE9802206D0 (en) 1998-06-22 1998-06-22 Novel compounds
AU48145/99A AU4814599A (en) 1998-06-22 1999-06-16 Novel compounds useful in pain management
EP99931709A EP1087940A1 (en) 1998-06-22 1999-06-16 Novel compounds useful in pain management
PCT/SE1999/001074 WO1999067203A1 (en) 1998-06-22 1999-06-16 Novel compounds useful in pain management
CA002335536A CA2335536A1 (en) 1998-06-22 1999-06-16 Novel compounds useful in pain management
ARP990102988A AR030143A1 (en) 1998-06-22 1999-06-22 1,4-SUBSTITUTED CYCLOHEXYL COMPOUNDS, USES OF SUCH COMPOUNDS FOR THE MANUFACTURE OF MEDICINES, ISOTOPICALLY LABELED COMPOUNDS, DIAGNOSTIC AGENT, PHARMACEUTICAL COMPOSITIONS, PROCESS FOR THE PREPARATION OF SUCH COMPOSIUMS IN THEIR COMPOSITE USE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9802206A SE9802206D0 (en) 1998-06-22 1998-06-22 Novel compounds

Publications (1)

Publication Number Publication Date
SE9802206D0 true SE9802206D0 (en) 1998-06-22

Family

ID=20411784

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9802206A SE9802206D0 (en) 1998-06-22 1998-06-22 Novel compounds

Country Status (6)

Country Link
EP (1) EP1087940A1 (en)
AR (1) AR030143A1 (en)
AU (1) AU4814599A (en)
CA (1) CA2335536A1 (en)
SE (1) SE9802206D0 (en)
WO (1) WO1999067203A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
JP4528901B2 (en) 2006-04-28 2010-08-25 塩野義製薬株式会社 Amine derivatives having NPYY5 receptor antagonistic activity
SA08290668B1 (en) 2007-10-25 2012-02-12 شيونوجي آند كو.، ليمتد Amine Derivatives having NPY Y5 receptor antagonistic activity and the uses thereof
US8273900B2 (en) 2008-08-07 2012-09-25 Novartis Ag Organic compounds
EP2389362B1 (en) 2009-01-21 2019-12-11 Oryzon Genomics, S.A. Phenylcyclopropylamine derivatives and their medical use
US8227618B2 (en) 2009-04-23 2012-07-24 Shionogi & Co., Ltd. Amine-derivatives having NPY Y5 receptor antagonistic activity and the uses thereof
JP5699152B2 (en) 2009-09-25 2015-04-08 オリゾン・ジェノミックス・ソシエダッド・アノニマＯｒｙｚｏｎ Ｇｅｎｏｍｉｃｓ Ｓ．Ａ． Lysine-specific demethylase-1 inhibitors and uses thereof
US8946296B2 (en) 2009-10-09 2015-02-03 Oryzon Genomics S.A. Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
WO2011106105A2 (en) 2010-02-24 2011-09-01 Oryzon Genomics, S.A. Inhibitors for antiviral use
US9186337B2 (en) 2010-02-24 2015-11-17 Oryzon Genomics S.A. Lysine demethylase inhibitors for diseases and disorders associated with Hepadnaviridae
WO2011131697A1 (en) 2010-04-19 2011-10-27 Oryzon Genomics S.A. Lysine specific demethylase-1 inhibitors and their use
EP3375775A1 (en) 2010-07-29 2018-09-19 Oryzon Genomics, S.A. Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
EP2598480B1 (en) 2010-07-29 2019-04-24 Oryzon Genomics, S.A. Cyclopropylamine derivatives useful as lsd1 inhibitors
WO2012045883A1 (en) 2010-10-08 2012-04-12 Oryzon Genomics S.A. Cyclopropylamine inhibitors of oxidases
WO2012072713A2 (en) 2010-11-30 2012-06-07 Oryzon Genomics, S.A. Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
EP2712315B1 (en) 2011-02-08 2021-11-24 Oryzon Genomics, S.A. Lysine demethylase inhibitors for myeloproliferative disorders
PE20141322A1 (en) * 2011-03-25 2014-10-05 Glaxosmithkline Intellectual Property (N 2) Limited CYCLOPROPYLAMINES AS INHIBITORS OF LYSINE-SPECIFIC DESMETILASE 1
EP2776394B1 (en) 2011-10-20 2018-12-26 Oryzon Genomics, S.A. (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
EP3736265A1 (en) 2011-10-20 2020-11-11 Oryzon Genomics, S.A. (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
AU2015214251B2 (en) 2014-02-07 2017-07-20 eXIthera Pharmaceuticals Inc. Therapeutic compounds and compositions
AU2018213637B2 (en) * 2017-01-24 2022-01-27 Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. LSD1 inhibitor and preparation method and application thereof
WO2020092592A1 (en) * 2018-10-30 2020-05-07 Exithera Pharmaceuticals, Inc. Therapeutic compounds and compositions
WO2021228146A1 (en) * 2020-05-12 2021-11-18 石药集团中奇制药技术（石家庄）有限公司 Use of lsd1 inhibitor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE627610A (en) *
DE701074C (en) * 1936-07-29 1941-01-08 Henkel & Cie Gmbh Process for the production of hydroaromatic nitrogen compounds
US4762949A (en) * 1979-06-20 1988-08-09 University Of Illinois Foundation Acyl and carbamimidoyl alkanediamines
DE19544685A1 (en) * 1995-11-30 1997-06-05 Thomae Gmbh Dr K Amino acid derivatives, medicaments containing these compounds and processes for their preparation
CA2268051A1 (en) * 1996-08-23 1998-02-26 Alanex Corporation Neuropeptide-y ligands

Also Published As

Publication number Publication date
AR030143A1 (en) 2003-08-13
EP1087940A1 (en) 2001-04-04
WO1999067203A1 (en) 1999-12-29
CA2335536A1 (en) 1999-12-29
AU4814599A (en) 2000-01-10

Similar Documents

Publication Publication Date Title
SE9802206D0 (en) Novel compounds
SE9604786D0 (en) New compounds
SE9504661D0 (en) New compounds
SE0101387D0 (en) Novel compounds
DE60045508D1 (en) DALDA ANALOGS AND THEIR USE
MY119403A (en) Novel compounds with analgesic effect.
ATE306261T1 (en) ANTITHROMBOTIC AGENTS
ATE297203T1 (en) ANTITHRBOTIC AGENTS
AP2002002637A0 (en) Novel piperazine
DE69931393D1 (en) ANTITHROMBOTIC AMIDE
ATE272633T1 (en) AROMATIC AMIDES
CY1107850T1 (en) THIADIAZYLOPIPERAZINE PRODUCT WITH USE IN APTROPIC OR IN ACTION AGAINST ALGUES
ATE233274T1 (en) OXYIMINOPREGNANCARBOLACTONE
SE9802208D0 (en) Novel compounds
SE0100569D0 (en) New compounds
SE0203070D0 (en) Novel compounds
SE0203303D0 (en) Novel Compounds
GEP20043227B (en) 5HT1 Antagonists for Antidepressant Therapy
ATE308540T1 (en) ANTITHROMBOTIC AGENTS
SE0203300D0 (en) Novel Compounds
UY27587A1 (en) THERAPEUTIC HETEROCICLES
SE9802209D0 (en) Novel compounds
FI934680A0 (en) ARYLMORFOLIN, FRAMSTAELLNING OCH ANVAENDING
SE9504662D0 (en) New compounds
ATE250610T1 (en) POTASSIUM CHANNEL BLOCKING AGENTS